Issue 15, 2023

Synthesis and evaluation of radioiodinated estrogens for diagnosis and therapy of male urogenital tumours

Abstract

The preparation of 24 estrogens, their estrogen receptor (ER) affinity and studies of radioiodinated estrogen binding to ER-positive male bladder tumor cells (HTB9) are described. The estrogens with the highest affinity were selected using fluorescence anisotropy assays. A 2,2,2-trifluoroethyl group at the 11β-position caused particularly promising affinity. (Radio)iodination was performed on the 17α-vinyl group. Binding studies on HTB9 cells revealed picomolar affinities of radioconjugates 19 and 31, indicating promising ability for targeting of urogenital tumors.

Graphical abstract: Synthesis and evaluation of radioiodinated estrogens for diagnosis and therapy of male urogenital tumours

Supplementary files

Article information

Article type
Communication
Submitted
23 Jan 2023
Accepted
15 Mar 2023
First published
20 Mar 2023
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2023,21, 3090-3095

Synthesis and evaluation of radioiodinated estrogens for diagnosis and therapy of male urogenital tumours

F. Braun, M. Jaschinski, P. Täger, V. Marmann, M. V. Brandenstein, B. Köditz, T. Fischer, S. Muñoz-Vázquez, B. Zimmermanns, M. Dietlein, F. Sudbrock, P. Krapf, D. Fischer, A. Heidenreich, A. Drzezga, S. Kirsch, M. Pietsch and K. Schomäcker, Org. Biomol. Chem., 2023, 21, 3090 DOI: 10.1039/D3OB00114H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements